Search

SARS-CoV-2 Mutations in Brazil: From Genomics to Clinical Conditions

Luis Timmers, Julia Peixoto, Rodrigo Ducati, Jose Fernando Bachega, Leandro Mattos Pereira, Rafael Andrade Caceres, Fernanda Majolo, Guilherme Liberato Da Silva, Debora Bublitz Anton, Marcia Inês Goettert, Odir Antônio Dellagostin, Joao Henriques, Leder Xavier, Stefan Laufer

Version 1 posted 19 February 2021

664

Downloads

1

Citations

Biological and Medicinal Chemistry

Working Paper

Application of In-Silico Reverse Vaccinology for Designing Multi-Epitope Vaccine Against Coronavirus

Kumar Sharp, Dr. Shubhangi Dange

Version 1 posted 09 June 2020

989

Downloads

Biological and Medicinal Chemistry

Working Paper

Investigating the Antiviral Therapeutic Potentialities of Marine Polycyclic Lamellarin Pyrrole Alkaloids as Promising Inhibitors for SARS-CoV-2 and Zika Main Proteases (Mpro)

Florbela Pereira, Loay Bedda, Mohamed A. Tammam, Abdul Kader Alabdullah, Reem K. Arafa, Amr El-Demerdash

Version 1 posted 03 October 2022

227

Downloads

Biological and Medicinal Chemistry

Working Paper

Are Losartan and Imatinib Effective Against SARS-CoV2 Pathogenesis? a Pathophysiologic-Based in Silico Study

Reza Nejat, Ahmad Shahir Sadr

Version 3 posted 04 November 2020

1,957

Downloads

1

Citations

Biological and Medicinal Chemistry

Working Paper

A Molecular Docking and Dynamic Simulation Study for the Inhibition of Porcine Corona Virus: Drug Repurposing Approach

Anupama Tiwari, Shweta Mishra, G. N. Darwhekar, Suman Mukhopadhyay

Version 2 posted 20 February 2023

193

Downloads

Biological and Medicinal Chemistry

Working Paper

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19

Sugandh Kumar, Pratima Kumari, Geetanjali Agnihotri, Preethy VijayKumar, Shaheerah Khan, Gulam Hussain Syed, Anshuman Dixit

Version 1 posted 27 May 2020

1,277

Downloads

1

Citations

Biological and Medicinal Chemistry

Working Paper

In silico drug repurposing of anticancer drug 5-FU and analogues against SARS-CoV-2 main protease: molecular docking, pharmacokinetics and chemical reactivity

Aristote Matondo, Washington Dendera, Bienfait K. Isamura, Koto-te-Nyiwa Ngbolua, Hilaire V.S. Mambo, Mayaliwa Muzomwe, Virima Mudogo

Version 2 posted 22 April 2022

277

Downloads

1

Citations

Theoretical and Computational Chemistry

Working Paper

Spectroscopic investigations, DFT calculations, molecular docking and MD simulations of 3-[(4-Carboxyphenyl) carbamoyl]-4-hydroxy-2-oxo-1, 2-dihydroxy quinoline-6-carboxylic acid.

P. K. Ranjith, Angel Ignatious, C. Yohannan Panicker, B. Sureshkumar, Stevan Armakovic, Sanja. J. Armakovic, C. Van Alsenoy, P. L. ANTO

Version 1 posted 11 February 2022

494

Downloads

Biological and Medicinal Chemistry

Working Paper

Simeprevir and Eltrombopag as Potential Inhibitors of SARS-CoV2 Proteases: A Molecular Docking and Virtual Screening Approach to Combat COVID-19

Ananta Swargiary, AKALESH Verma, Manita Daimari, Mritunjoy Kumar Roy

Version 1 posted 21 September 2020

527

Downloads

Biological and Medicinal Chemistry

Working Paper

Investigating the Structure-Activity Relationship of Laulimalides Marine Macrolides as Promising Inhibitors for SARS-CoV-2 Main Protease (Mpro)

Alaa M. Elgohary, Abdo A. Elfiky, Florbela Pereira, Mariam I. Gamal El-Din, Mohamed A. Tammam, Mohamed Sebak, Sherif I. Hamdallah, Emad Shehata, Amr El-Demerdash

Version 1 posted 08 May 2023

160

Downloads

Refine Search

26 results in SARS-CoV2, main-protease, S1 receptor binding domain, hydroxychloroquine, curcumin, ANCHOR, Molecular docking in Keywords: SARS-CoV2, main-protease, S1 receptor binding domain, hydroxychloroquine, curcumin, ANCHOR, Molecular docking

SARS-CoV-2 Mutations in Brazil: From Genomics to Clinical Conditions

Application of In-Silico Reverse Vaccinology for Designing Multi-Epitope Vaccine Against Coronavirus

Investigating the Antiviral Therapeutic Potentialities of Marine Polycyclic Lamellarin Pyrrole Alkaloids as Promising Inhibitors for SARS-CoV-2 and Zika Main Proteases (Mpro)

Are Losartan and Imatinib Effective Against SARS-CoV2 Pathogenesis? a Pathophysiologic-Based in Silico Study

A Molecular Docking and Dynamic Simulation Study for the Inhibition of Porcine Corona Virus: Drug Repurposing Approach

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19

In silico drug repurposing of anticancer drug 5-FU and analogues against SARS-CoV-2 main protease: molecular docking, pharmacokinetics and chemical reactivity

Spectroscopic investigations, DFT calculations, molecular docking and MD simulations of 3-[(4-Carboxyphenyl) carbamoyl]-4-hydroxy-2-oxo-1, 2-dihydroxy quinoline-6-carboxylic acid.

Simeprevir and Eltrombopag as Potential Inhibitors of SARS-CoV2 Proteases: A Molecular Docking and Virtual Screening Approach to Combat COVID-19

Investigating the Structure-Activity Relationship of Laulimalides Marine Macrolides as Promising Inhibitors for SARS-CoV-2 Main Protease (Mpro)

26 results in Keywords: SARS-CoV2, main-protease, S1 receptor binding domain, hydroxychloroquine, curcumin, ANCHOR, Molecular docking